Sg Americas Securities, LLC Kura Oncology, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$13.42 - $23.53 $69,435 - $121,744	5,174 New	5,174 $110,000
Q2 2023 Jul 10, 2023	BUY	$9.62 - $13.99 $94,833 - $137,913	9,858 Added 36.34%	36,983 $391,000
Q1 2023 Apr 28, 2023	BUY	$10.71 - $14.6 $196,881 - $268,391	18,383 Added 210.28%	27,125 $332,000
Q4 2022 Feb 02, 2023	BUY	$11.23 - $16.9 $393 - $591	35 Added 0.4%	8,742 $108,000
Q3 2022 Oct 31, 2022	SELL	$12.01 - $19.45 $555,006 - $898,823	-46,212 Reduced 84.15%	8,707 $119,000
Q2 2022 Jul 29, 2022	SELL	$10.71 - $18.33 $455,839 - $780,161	-42,562 Reduced 43.66%	54,919 $1.01 Million
Q1 2022 Apr 29, 2022	SELL	$11.78 - $16.98 $911,418 - $1.31 Million	-77,370 Reduced 44.25%	97,481 $1.57 Million
Q4 2021 Feb 07, 2022	BUY	$12.22 - $19.57 $691,041 - $1.11 Million	56,550 Added 47.8%	174,851 $2.45 Million
Q3 2021 Nov 01, 2021	BUY	$15.42 - $21.72 $287,598 - $405,099	18,651 Added 18.72%	118,301 $2.22 Million
Q2 2021 Aug 12, 2021	BUY	$20.85 - $29.88 $17,472 - $25,039	838 Added 0.85%	99,650 $2.08 Million
Q1 2021 May 13, 2021	BUY	$24.75 - $39.14 $241,337 - $381,654	9,751 Added 10.95%	98,812 $2.79 Million
Q4 2020 Feb 04, 2021	SELL	$29.0 - $41.62 $370,127 - $531,196	-12,763 Reduced 12.53%	89,061 $2.91 Million
Q3 2020 Nov 09, 2020	BUY	$16.3 - $30.64 $766,295 - $1.44 Million	47,012 Added 85.77%	101,824 $3.12 Million
Q2 2020 Jul 20, 2020	BUY	$7.95 - $18.81 $315,559 - $746,625	39,693 Added 262.54%	54,812 $893,000
Q1 2020 Apr 30, 2020	BUY	$6.45 - $14.04 $45,840 - $99,782	7,107 Added 88.7%	15,119 $150,000
Q4 2019 Jan 28, 2020	SELL	$12.97 - $15.94 $1.24 Million - $1.53 Million	-95,826 Reduced 92.28%	8,012 $110,000
Q3 2019 Nov 04, 2019	BUY	$14.75 - $20.87 $1.43 Million - $2.02 Million	96,885 Added 1393.43%	103,838 $1.58 Million
Q2 2019 Jul 29, 2019	BUY	$14.71 - $19.79 $102,278 - $137,599	6,953 New	6,953 $137,000

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$69 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.8 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$52.3 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.8 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$39 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account